Kotyark Industries Limited reported a 9% year-on-year rise in consolidated net profit to ₹446.19 lakh for the quarter ended June 30, 2026 (Q1FY27). The company’s revenue from operations grew 11.5% to ₹9,198.08 lakh, driven by higher operational throughput despite ongoing regulatory scrutiny.

The Vadodara-based biofuel manufacturer published its first unaudited quarterly results since migrating from the SME platform to the Main Board on March 12, 2026. The Board of Directors approved the standalone and consolidated financial results on September 7, 2026, alongside the limited review report issued by statutory auditors Talati & Talati LLP.

Financial Performance

Consolidated revenue from operations stood at ₹9,198.08 lakh in Q1FY27, up from ₹8,246.49 lakh in the corresponding period of FY26. Standalone revenue also expanded, reaching ₹8,491.85 lakh compared to ₹7,673.71 lakh in Q1FY26.

Profit before tax for the consolidated entity was ₹747.20 lakh, an increase from ₹572.42 lakh in the prior-year quarter. After accounting for a total tax expense of ₹301.01 lakh, the net profit attributable to owners of the company was ₹383.77 lakh.

Earnings per share (basic and diluted) for the consolidated entity were ₹0.34, restated retrospectively following a 10:1 bonus share issue during the quarter. The standalone EPS was ₹0.09.

Operational and Regulatory Updates

The company disclosed that it ceased to be a partner in Asia Bio Fuels LLP and Parth Renewable Energy LLP effective April 1, 2026. These entities were de-merged from the consolidated financial results as the company no longer holds control over them.

Regulatory proceedings regarding the company’s registration with the Bio-Fuel Authority, Government of Rajasthan, remain pending. Authorities seized four storage tanks containing raw material (Veg Ester) at the Swaroopganj unit. However, the Rajasthan High Court permitted operations to continue to fulfill supply commitments to Oil Marketing Companies. Management stated there has been no loss of production or disruption in supplies.

What the Numbers Show

A divergence exists between standalone and consolidated profitability. While standalone net profit declined 7.9% YoY to ₹105.98 lakh due to higher cost of materials consumed relative to revenue, the consolidated net profit grew 9.1%. This growth is largely attributable to the performance of subsidiary Kotyark Bio Specialities Limited, which reported a net profit of ₹340.49 lakh for the quarter, significantly offsetting the parent company’s margin pressure.

Kotyark Industries shareholders approved all 12 resolutions at the company’s 10th Annual General Meeting held on August 22, 2026. The unanimous backing included a final dividend of ₹5 per equity share. Management also highlighted the company’s migration to the NSE and BSE Main Board in March 2026 and the subsequent adoption of Indian Accounting Standards (Ind AS).

The virtual meeting, chaired by Chairman cum Managing Director Gaurang Rameshchandra Shah, concluded at 12:26 pm. Scrutinizer M/s. SCS & CO LLP confirmed that promoters voted in favor of every resolution. Key management personnel, including CFO Dhruvi Mihir Shah and Non-Executive Director Bhavini Gaurang Shah, briefed members on strategic initiatives and governance updates.

Voting Results and Governance

Shareholders on record as of August 15, 2026, participated via remote e-voting and video conferencing. The company received votes from 14,682 shareholders. Promoter and promoter group entities held 64,830,744 shares and voted 100% in favor of all ordinary and special resolutions.

Statutory auditors M/s. Manubhai & Shah LLP issued an unqualified report for FY25-26. The AGM also ratified the appointment of M/s. Mittal V Kothari & Associates as secretarial auditor, despite minor annotations noted during the meeting.

Operational Highlights and Order Book

Management emphasized that FY25-26 was characterized by capacity expansion despite relatively low utilization rates, indicating substantial headroom for future growth. The company received Letters of Intent (LOIs) aggregating approximately ₹223.53 crore during the fiscal year.

Key operational developments included:

• Receipt of an OMC order worth ₹173.45 crore in FY26-27.
• Establishment of a dedicated Glycerine Processing Unit at Sirohi to target pharmaceutical, food, and personal care sectors.
• Successful testing and durability trials of B20 and B30 biodiesel blends by the Automotive Research Association of India (ARAI).
• Achievement of ISO 9001:2015 certification for quality management systems covering Bio Diesel and Crude Glycerine manufacture.

Strategic Outlook and CSR

Chairman Gaurang Rameshchandra Shah outlined priorities for FY26-27, targeting a capacity utilization increase to 60-70% over the next two to three years. The company aims to broaden its customer base across OMC, industrial, and bulk channels. Its business model relies on waste and non-edible feedstock, supported by a Zero Effluent Discharge model.

The company earned approval for 57,874 Carbon Credits under the Verra standard for the period September 15, 2020, to March 31, 2022. Additionally, Kotyark incurred ₹46.55 lakhs towards Corporate Social Responsibility (CSR) activities during FY25-26. Non-Executive Director Bhavini Gaurang Shah noted that Chairman Gaurang Rameshchandra Shah received a Certificate of Excellence from the World Book of Records in London in June 2026 for his contributions to renewable energy.

What the Numbers Show

The receipt of a single OMC order worth ₹173.45 crore constitutes approximately 78% of the total ₹223.53 crore in LOIs received during FY25-26. This concentration highlights the company’s growing dependency on large-scale institutional buyers rather than fragmented retail or small industrial clients for near-term revenue realization.